Ultragenyx Pharmaceutical RARE at 2639 Buy Sell or Hold 20260514 Guggenheim GOF Stalls at 1149 Consolidation Phase 20260514 Q4 Earnings Season Heats Up BEL Zydus Lifesciences RITES and More Report Results on May 19 Dover DOV Stalls at 21024 Consolidation Phase 20260518 GXAI Q1 2026 Earnings EPS Misses Estimates No Revenue Reported IMNN Q1 2026 Earnings Narrowerthanexpected loss drives small share gain RTX Q1 2026 Earnings Solid EPS Beat Driven by Strong Commercial and Defense Demand ARDX Q1 2026 Earnings EPS Misses Estimates by 142 Revenue Not Disclosed WGRX Q1 2026 Earnings EPS Loss of 007 Triggers Sharp Decline Broadstone Net Lease BNL Hovers Near 2040 Amid Modest Trading Citius Oncology Inc CTOR Edges Higher Can It Sustain Momentum Above 086 Karat Packaging Holds Steady KRT Edges Higher Amid Narrow Trading Range Quantumsphere Acquisition Corp QUMS Holds Steady at 1019 as Trading Range Narrows Neuraxis Inc NRXS Q1 2026 Earnings EPS Surpasses Estimates Amid Operational Progress OLB Group Q4 2025 Earnings Narrowed Loss Beats Estimates Shares Rise HAE Q1 2026 Earnings EPS Slightly Beats Estimates Shares Rally ES Q1 2026 Earnings Slight EPS Miss Amid Utility Operations XERS Q1 2026 Earnings EPS Surprise of 21765 as Company Achieves Profitability Limoneira LMNR Q1 2026 Earnings EPS Misses Estimates Amid Challenging Growing Season GIGM Q3 2025 Earnings Narrowed Losses Amid Strategic Restructuring Telus Q1 2026 Earnings EPS Beats Expectations Amid Cautious Growth Outlook